Journal profile · PATHOLOGY
Turkish Journal of Pathology
ISSN 1018-5615 · eISSN 1309-5730 · Federation of Turkish Pathology Societies · Turkey
Turkish Journal of Pathology: CAS Zone 4 · Medicine (2025 upgraded edition); diamond open access (no APC); no APC; review about 14 weeks (community reports); acceptance rate 18% (journal website); 47 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Turkish Journal of Pathology is published by Federation of Turkish Pathology Societies and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Sarcoma Diagnosis and Treatment, Cancer and Skin Lesions and Breast Lesions and Carcinomas, together about 20% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Journal’s aims are to publish articles in all fields of surgical pathology including autopsy, cytopathology, digital pathology (including information technologies) and molecular pathology as well as clinicopathological studies. The Journal is open to all studies using immunohistochemical, ultrastructural techniques and molecular methods in the diagnostic pathology field. Studies that recommend new techniques and methods, electronic education, and quality control and quality assurance-related studies are also within the journal’s scope.
From the journal's Aims & Scope
Research area (LetPub): PATHOLOGY
Editor-in-chief Volkan AdsayPublisher website
Editorial board by country: none in mainland China; most named United States 14, Türkiye 13, Italy 4, United Kingdom 3, Portugal 3 (42 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Sarcoma Diagnosis and TreatmentMedicine8.9%
- Cancer and Skin LesionsMedicine5.8%
- Breast Lesions and CarcinomasMedicine5.3%
- Cervical Cancer and HPV ResearchMedicine5%
- Oral and Maxillofacial PathologyDentistry5%
- Soft tissue tumor case studiesMedicine4.3%
- Tumors and Oncological CasesMedicine4.3%
- Neuroendocrine Tumor Research AdvancesMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPMCPubMedPublisher website
Other: EBSCO, Index Medicus, TR Index, Ulrichs Web, Hinari, Worldcat, Sobiad
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 4.1LetPub ·
- SJR 2026-06
- 0.54LetPub ·
- SNIP 2026-06
- 1.73LetPub ·
- h-index
- 26OpenAlex ·
- i10-index
- 174OpenAlex ·
- 2-year mean citedness
- 0.58OpenAlex ·
- Self-citation rate
- 6.7%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 19LetPub ·
Articles by year OpenAlex count · 817 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 1 | 1 | 0 |
| 2025 | 47 | 47 | 13 |
| 2024 | 28 | 28 | 31 |
| 2023 | 14 | 14 | 47 |
| 2022 | 29 | 29 | 290 |
| 2021 | 46 | 46 | 228 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 14 weeksLetPub ·
- Acceptance rate (publisher)
- 18%Publisher website ·
- Submission to first decision
- 19 daysPublisher website ·
- Submission to publication (journal-reported)
- about 14 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| LetPub | No APC | No | — | |
| Publisher website | No APC | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 3–5
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
- Cover letter
- Required
- Not considered
- case series; review articles
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Plagiarism
- AI use
AI tools cannot be listed as authors; use must be disclosed in Materials and Methods. Model summary
AI tools cannot be listed as an author of a paper.
Source ↗Publisher website ·- Authorship
Authorship per ICMJE criteria. Model summary
The Turkish Journal of Pathology accepts the criteria of the International Committee of Medical Journal Editors
Source ↗Publisher website ·- Conflicts of interest
Conflict of interest declaration required on title page. Model summary
A conflict of interest is defined as any financial, personal, academically competitive or intellectual relationship between the author, reviewer or editor that involves article submission, referee evaluation, editorial decision and author-referee-editor correspondence and that could lead to a prejudiced and unfair action during the evaluation stage.
Source ↗Publisher website ·- Publication ethics
COPE member; COPE position statement on AI implemented. Model summary
Turkish Journal of Pathology is a member of Committee of Publication Ethics (COPE) and the position statement of COPE is implemented in our journal
Source ↗Publisher website ·- License & copyright
Authors retain copyright; open access under CC BY. Model summary
The authors own the copyright for the articles published in Turkish Journal of Pathology. All articles are published as open access under the Creative Commons Attribution License (CC BY).
Source ↗Publisher website ·- Open access
Adopts Budapest Open Access Initiative declaration. Model summary
Turkish Journal of Pathology adopts the Open Access Declaration published by Budapest Open Access Initiative in Feb, 2002.
Source ↗Publisher website ·- Plagiarism
Plagiarism screening via iThenticate for all new submissions. Model summary
All new submissions are screened for plagiarism by similarity check software (Ithenticate).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Federation of Turkish Pathology Societies
- Country or region
- Turkey
- Language
- English
- ISSN
- 1018-5615
- Electronic ISSN
- 1309-5730
- Society / sponsor
- Federation of Turkish Pathology Societies
- Latest issue on the website
- Volume 42, Issue 3 (September 2026)
- Official links
FAQ
Frequently asked questions about Turkish Journal of Pathology
What CAS zone is Turkish Journal of Pathology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Turkish Journal of Pathology is in Zone 4 of Medicine, and in Zone 4 of the minor category Pathology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Turkish Journal of Pathology?
Authors report an average review time of about 14 weeks; the journal's website gives an acceptance rate of 18%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Turkish Journal of Pathology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 3–5; Reference style: Vancouver; First submission: Free format: the journal's layout is not required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Turkish Journal of Pathology based?
Of the 42 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (14), Türkiye (13) and Italy (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Turkish Journal of Pathology?
According to LetPub and DOAJ records, Turkish Journal of Pathology is indexed in ESCI, Scopus and DOAJ. The journal's website also lists MEDLINE, PMC and PubMed; that list has not been checked against each database.
Is Turkish Journal of Pathology open access, and what is the APC?
Turkish Journal of Pathology is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .